)
|
|
|
|
|
PVT6101
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVT6102
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVT17083
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVT1312
|
| Lifescience Market |
|
2 ug |
|
|
|
|
B1114-25
|
| ApexBio |
|
25 mg |
|
Description: T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.
|
|
|
|
|
|
B1114-5
|
| ApexBio |
|
5 mg |
|
Description: T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.
|
|
|
|
|
|
B1114-5.1
|
| ApexBio |
|
10 mM (in 1mL DMSO) |
|
Description: T 705(Favipiravir) is a RNA-directed RNA polymerase NS5B inhibitor.
|
|
 and CRE co-expression stable cell line (puromycin))
|
|
|
SC021-Puro
|
| GenTarget |
|
2 x 106 cell/ml x 1ml |
|
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with Puromycin marker.
|
|
)
|
|
|
|
|
|
|
|
PVT10889
|
| Lifescience Market |
|
2 ug |
|
 and CRE co-expression stable cell line (GFP-Blasticidin))
|
|
|
SC021-GB
|
| GenTarget |
|
2 x 106 cell/ml x 1ml |
|
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with GFP-Blasticidin fusion dual marker.
|
|
 and CRE co-expression stable cell line (RFP-puromycin))
|
|
|
SC021-RP
|
| GenTarget |
|
2 x 106 cell/ml x 1ml |
|
Description: Luciferase (firefly) and CRE recombinase co-expression stable cell line with RFP-Puromycin fusion dual marker.
|
|
GFP-9xGGS-Cre-6xHis Plasmid)
|
|
|
PVT17107
|
| Lifescience Market |
|
2 ug |
|
|
|
|
|
 Antibody)
|
|
|
|
|
 Antibody)
|
|
|
|
|
|
|
|
|
CSB-PA586999-
|
| Cusabio |
|
|
|
Description: A polyclonal antibody against STAT3 (Ab-705). Recognizes STAT3 (Ab-705) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200
|
|
|
|
|
|
CSB-PA586999-100ul
|
| Cusabio |
|
100ul |
|
Description: A polyclonal antibody against STAT3 (Ab-705). Recognizes STAT3 (Ab-705) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200
|
|
 Antibody)
|
|
|
CSB-PA292268-
|
| Cusabio |
|
|
|
Description: A polyclonal antibody against NTRK2 (Ab-705). Recognizes NTRK2 (Ab-705) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200
|
|
|
|
|
|
CSB-PA292268-100ul
|
| Cusabio |
|
100ul |
|
Description: A polyclonal antibody against NTRK2 (Ab-705). Recognizes NTRK2 (Ab-705) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF;WB:1:500-1:1000, IF:1:100-1:200
|
|
)
|
|
|
A4376-10
|
| ApexBio |
|
10 mg |
|
Description: IC50: 6 ?M for CETP inhibition in human plasmaCholesteryl ester transfer protein (CETP) is a plasma protein that transfers neutral lipids among the lipoproteins.
|
|
|
|
|
|
A4376-100
|
| ApexBio |
|
100 mg |
|
Description: IC50: 6 ?M for CETP inhibition in human plasmaCholesteryl ester transfer protein (CETP) is a plasma protein that transfers neutral lipids among the lipoproteins.
|
|
|
|
|
|
A4376-5
|
| ApexBio |
|
5 mg |
|
Description: IC50: 6 ?M for CETP inhibition in human plasmaCholesteryl ester transfer protein (CETP) is a plasma protein that transfers neutral lipids among the lipoproteins.
|
|
|
|
|
|
A4376-5.1
|
| ApexBio |
|
10 mM (in 1mL DMSO) |
|
Description: IC50: 6 ?M for CETP inhibition in human plasmaCholesteryl ester transfer protein (CETP) is a plasma protein that transfers neutral lipids among the lipoproteins.
|
|
|
|
|
|
A4376-50
|
| ApexBio |
|
50 mg |
|
Description: IC50: 6 ?M for CETP inhibition in human plasmaCholesteryl ester transfer protein (CETP) is a plasma protein that transfers neutral lipids among the lipoproteins.
|
|
)
|
|
|
LF-PA20471
|
| Abfrontier |
|
100 ul |
|
Description: Rabbit polyclonal to STAT3
|
|
|
|
|
MPM00667
|
| ABM |
|
150 ul / 10 uM |
|
|
|
|
ADV-005
|
| Cell Biolabs |
|
50 ?L |
|
Description: Premade recombinant adenovirus containing the Cre gene
|
|
|
|
|
A18151-100ul
|
| Abclonal |
|
100 ul |
|
|
|
|
|
A18151-200ul
|
| Abclonal |
|
200 ul |
|
|
|
|
|
A18151-20ul
|
| Abclonal |
|
20 ul |
|
|
|
|
|
A18151-50ul
|
| Abclonal |
|
50 ul |
|
|
|
|
PVT12294
|
| Lifescience Market |
|
2 ug |
|
|
|
|
PVT19014
|
| Lifescience Market |
|
2 ug |
|
|
|
|
STJ11100121
|
| St John's Laboratory |
|
100 µl |
|
|
|
|
|
STJ140003
|
| St John's Laboratory |
|
300 µg |
|
Description: Goat polyclonal antibody to Cre recombinase. Cre recombinase is a tyrosine recombinase enzyme derived from the P1 bacteriophage. The enzyme (38 kDa) is a member of the Integrase family of site specific recombinase and it is known to catalyse the site specific recombination event between two DNA recognition sites (loxP sites).
|
|
 Creatininase (500 U/mg))
|
|
|
CRE-02
|
| Alpha Diagnostics |
|
500,000 U |
|
 Antibody)
|
|
|
A01388-1
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal TrkB (Ab-705) Antibody. Validated in IF, WB and tested in Human, Mouse, Rat.
|
|
)
|
|
|
APR11198G
|
| Leading Biology |
|
0.1ml |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human STAT3 (Ab-705). This antibody is tested and proven to work in the following applications:
|
|
 Conjugated Antibody)
|
|
|
|
|
MNM02869
|
| ABM |
|
2 x 5.0 nmol |
|
|
|
|
MIM02869
|
| ABM |
|
2 x 5.0 nmol |
|
|
|
|
AAV-310
|
| Cell Biolabs |
|
50 ?L |
|
Description: Cre control virus of AAV serotype 2.
|
|
|
|
|
AAV-311
|
| Cell Biolabs |
|
50 ?L |
|
Description: Cre control virus of AAV serotype 1.
|
|
|
|
|
AAV-313
|
| Cell Biolabs |
|
50 ?L |
|
Description: Cre control virus of AAV serotype 3.
|
|
|
|
|
AAV-314
|
| Cell Biolabs |
|
50 ?L |
|
Description: Cre control virus of AAV serotype 4.
|
|
|
|
|
AAV-315
|
| Cell Biolabs |
|
50 ?L |
|
Description: Cre control virus of AAV serotype 5.
|
|
|
|
|
AAV-316
|
| Cell Biolabs |
|
50 ?L |
|
Description: Cre control virus of AAV serotype 6.
|
|
|
|
|
AAV-401
|
| Cell Biolabs |
|
10 µg |
|
Description: Use this control vector to co-transfect along with AAV packaging vectors to produce a recombinant AAV control.
|
|
, CMV lentivirus)
|
|
|
LVP297
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker, provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus)
|
|
|
LVP336
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker, provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus)
|
|
|
LVP339
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Puromycin marker, provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP519
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker, provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP520
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Puromycin marker, provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP521
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker, provided in DMEM medium with 10% FBS.
|
|
, CAG lentivirus)
|
|
|
LVP573
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Puromycin marker, provided in DMEM medium with 10% FBS.
|
|
, CAG lentivirus)
|
|
|
LVP574
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Blasticidin marker, provided in DMEM medium with 10% FBS.
|
|
, CAG lentivirus)
|
|
|
LVP575
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Neomycin marker, provided in DMEM medium with 10% FBS.
|
|
|
|
|
PVT10799
|
| Lifescience Market |
|
2 ug |
|
 Antibody)
|
|
|
|
|
,
CAG lentivirus)
|
|
|
LVP576
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the GFP marker under the same suCAG promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
,
CAG lentivirus)
|
|
|
LVP577
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the RFP marker under the same suCAG promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
,
CAG lentivirus)
|
|
|
LVP578
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the RFP marker under the same suCAG promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
|
|
|
LVP804
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. No any antibioic selection marker. Virus provided in DMEM medium with 10% FBS.
|
|
|
|
|
LVP805
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. No any antibioic selection marker. Virus provided in DMEM medium with 10% FBS.
|
|
|
|
|
PVT10895
|
| Lifescience Market |
|
2 ug |
|
|
|
|
02-705
|
| Sceti |
|
100ng |
|
Description: The Rat ; Rat embryonic fibroblast is available in Europe and for worldwide shipping via Gentaur.
|
|
 Human TIE-2 Fc Chimera)
|
|
|
RP-705
|
| Alpha Diagnostics |
|
10 ug |
|
 Conjugated Antibody)
|
|
, CMV lentivirus)
|
|
|
LVP013
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus)
|
|
|
LVP027
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus, in PBS )
|
|
|
LVP297-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
, lentiviral particles)
|
|
|
LVP304
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus in PBS )
|
|
|
LVP336-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
, CMV lentivirus)
|
|
|
LVP337
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus)
|
|
|
LVP338
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus in PBS )
|
|
|
LVP339-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
, CMV lentivirus)
|
|
|
LVP407
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, CMV lentivirus)
|
|
|
LVP408
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, lentiviral particles)
|
|
|
LVP409
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, lentiviral particles)
|
|
|
LVP410
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus in PBS )
|
|
|
LVP519-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
, EF1a lentivirus in PBS )
|
|
|
LVP520-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
, EF1a lentivirus, in PBS )
|
|
|
LVP521-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
, EF1a lentivirus)
|
|
|
LVP522
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP523
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP524
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP525
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP526
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
, EF1a lentivirus)
|
|
|
LVP527
|
| GenTarget |
|
1x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the GFP marker under the same suEF1a promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS.
|
|
,
CAG lentivirus in PBS)
|
|
|
LVP573-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
,
CAG lentivirus in PBS)
|
|
|
LVP574-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
,
CAG lentivirus, in PBS)
|
|
|
LVP575-PBS
|
| GenTarget |
|
5 x107 IFU/ml x 200ul |
|
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution
|
|
|
|
|
SC004-Bsd
|
| GenTarget |
|
2 x 106 cell/ml x 1ml |
|
Description: CRE recombinase stable cell line with Blasticidin resistance
|
|
